+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

EHA Bilateral Collaborative Grant

European Hematology Association

The EHA Bilateral Collaborative Grant supports collaboration between two independent research groups:

With complementarity of expertise
Showing a mutual need to answer a specific research question

The grant:

Lasts for a period of two years
Provides an annual financial award of at €160,000 to be divided equally between the two research groups

To reflect the collaborative spirit of the grant, the budget must be divided 50:50 between the two PIs. If this is not the case, a justification must be provided. In any case, no more than 70% of the total grant should be allocated to one PI.

You can use your grant for:

Personnel costs, including the applicant or the costs of hiring other research staff to work directly on the project
Lab consumables
Small equipment
Miscellaneous expenses, such as publication of your project’s results

You must use some of your grant to pay for:

Attendance at the EHA Congress whilst your project is active (maximum €2,000 per PI per year)
A final audit of your project’s financial costs (maximum €2,000 per PI)

You cannot use your grant to cover:

Overhead costs
Excessive travel costs
Costs that are covered by another fund, even if new funding is acquired during the project, that make all or part of the grant redundant

If you acquire additional funding, you must email us about this within 30 days of its awarding. You must also tell us how you’ll use the grants together.

AI Based Application Success Predictor

🎯 1. Membership & Institutional Endorsements

You must be an active EHA member or guest to apply 

Your home and host institutions must confirm support, including approval of the grant conditions and protected time for Physician Scientist applicants 

🧬 2. Career-Stage & Scheme Selection

Junior, Advanced, and Physician-Scientist Research Grants offer €50K–€80K/year for 3 years—choose based on post-PhD experience (4–8 years, or with life-event extension) .

Innovation Grants support translational and collaborative consortia (€300K total, ≥3 PIs from ≥3 countries, including at least one junior member and one from eligible Eastern European nation) .

Bilateral Collaborative and Kick-Off Grants offer targeted funding for early-stage hypothesis-driven projects and international lab pairings .

🧠 3. Scientific Quality & Translational Potential

Your research must be basic or translational (lab-based or connected to clinical trials) in hematology—not purely clinical or health economics .

Innovation Grants require high‑risk, high‑gain objectives with clear deliverables leading to larger EU funding .

👥 4. Team Composition & Peer Review Strength

Innovation Grants must include a strong multinational team (≥3 PIs) with demonstrated complementary expertise .

Review panels judge both project merit (significance, novelty, methods, environment, feasibility) and investigator strength (track record, collaboration ability) .

📊 5. Budget Realism & Timeline Matching

Budgets must be clearly itemized, justified, and matched to the proposed timeline .

🕰️ 6. Structured, Multi-Stage Review & Interviews

After eligibility checks and internal screening, applications undergo expert external peer reviews (≥3), with top candidates invited to interviews (Innovation Grants: scored by Committee; Research Grants: video interviews ~25 min) .

🔧 7. Administrative Rigor & Reporting Obligations

Omission of required attachments (budget, mentor/institution letters) leads to rejection .

Successful applicants enter grant agreements, submit interim/final scientific + audited financial reports, acknowledge EHA funding in publications, and use Researchfish for tracking impact

✅ Summary Table

Success Predictor	What to Demonstrate
EHA Membership & Endorsement	Active membership, institutional buy-in
Correct Scheme Selection	Match grant to your career level and project type
Scientific Innovation	Novel, basic/translational hematology research
Strong Collaborative Team	Multinational consortia and mentorship
Solid Proposal & Budget	Rigorous methods, realistic budget & timeline
Alignment with Review Criteria	Significance, originality, feasibility, investigator merit
Reporting & Compliance	Complete paperwork; commit to reporting & fundraising impact

🛠️ Strategic Tips

Confirm membership and start early on recommendation letters and grant documentation.

Pick the right funding route (Junior/Advanced/Innovation) based on your stage and project scope.

Design your project for translation, aiming to leverage future opportunities like Horizon Europe.

Build your consortium wisely, especially for Innovation Grants (≥3 European PIs).

Craft your budget and timeline meticulously—align each cost with project aims.

Prepare thoroughly for interviews, summarizing your project clearly in 10 minutes.

Organize grant administration with your institution ahead of time, anticipating reports and impact tracking.

Specialties

Hematology

Eligibility Requirements

Both principal investigators (PIs) must be EHA members.
Both PIs must be basic and/or translational researchers. 
Both PIs must be independent researchers or group leaders and have full appointments at academic institutes or proven equivalents.
The PIs must conduct their research in two different countries in Europe. 
At least one of the PIs must be a junior independent group leader, within five years of conducting independent research. 
If an applicant is a physician scientist, at least 50% of their time should be dedicated to lab research.

Unfortunately, you are not eligible if your proposal relates to:

Purely clinical research projects
Projects in health economics
Other non-lab-based research

Sponsor Details

Sponsor Institute/Organizations: European Hematology Association

Sponsor Type: Corporate/Non-Profit

Address: Koninginnegracht 12b 2514 AA The Hague The Netherlands

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity